CBI's Biosimiliars Summit

Jan. 23, 2018 – Jan. 24, 2018  • Alexandria, VA

Visit the Event Page See the Agenda View the Event Speakers

calendar Add to calendar

As more biosimilar products continue to be added to the FDA pipeline, it is critical that pharmaceutical companies develop strategies to comply with evolving regulations, mitigate risk and execute long-term decisions to prepare for success. At CBI’s 13th Biosimilars Summit, you’ll gain insights from industry experts on the tools and strategies needed to prepare for the impending changes impacting all elements of the healthcare industry.